Prescription medicine
Lerodalcibep Brand names: Lerochol
Lerodalcibep (Lerochol) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the lerodalcibep FDA label on DailyMed (effective July 28, 2026); every lerodalcibep label on DailyMed.
Highlights of the record
FDA label of July 28, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageLEROCHOL TM is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH).
Forms and strengths
- 300 mg/1.2ml
Injection (solution).
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
What is lerodalcibep used for?
From the label: indications and usageLEROCHOL TM is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). LEROCHOL is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor indicated as an adjunct to diet and exercise: to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH).
Conditions named in the indications of lerodalcibep's FDA labels, with every medicine labeled for each:
Source: FDA drug label (LEROCHOL), LIB Therapeutics, Inc., effective July 28, 2026 (SPL set 422f8b04-6ce8-4e64-a0a9-0ccc9a4a5860), via openFDA; the full label on DailyMed
Is there a generic for lerodalcibep (Lerochol)?
No generic lerodalcibep is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What else is labeled for the same conditions as lerodalcibep?
1 other medicine is given the same way (subcutaneous) and in the same FDA class as lerodalcibep or labeled mainly for the same use (high cholesterol), the same class first. High cholesterol lists all 25 medicines labeled for it, by any route. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.
| Medicine | Shared indication | Generic labelers (subcutaneous) | Pharmacy cost | Shortage |
|---|---|---|---|---|
| Inclisiran | High cholesterol | none listed | n/a | No current entry |
Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)
What next?
- Check an interaction
- what two or more labels say about each other